News & Updates

Show Multimedia Only

Hypercholesterolemia does not worsen cognitive decline in arterial hypertension

21 May 2026

The presence of hypercholesterolemia shows no negative impact on cognitive function among individuals with hypertension, reports a study.

Hypercholesterolemia does not worsen cognitive decline in arterial hypertension

21 May 2026

BP shows linear relationship with cardiovascular, renal outcomes in T2D

20 May 2026

Blood pressure (BP) demonstrates a linear or monotonic association with most cardiovascular and renal outcomes in individuals with type 2 diabetes (T2D), reports a study.

BP shows linear relationship with cardiovascular, renal outcomes in T2D

20 May 2026

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

19 May 2026 by

In a recent study from Singapore, housing type and sedentary behaviour have emerged as novel risk factors for diabetic peripheral neuropathy.

Housing type, sedentary behaviour influence risk of diabetic peripheral neuropathy

19 May 2026

GLP-1 RA prevents relapse, cuts weight in AUD patients with MetD

16 May 2026 by

Exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) demonstrates superiority over current FDA-approved pharmacotherapies for alcohol use disorder (AUD), reducing the risk of AUD after 1 year of therapy, reports a study presented at DDW 2026.

GLP-1 RA prevents relapse, cuts weight in AUD patients with MetD

16 May 2026

Saturated fat intake ups risk of several cancers

15 May 2026

Individuals with high intakes of total and saturated fats are at increased risks of several cancers, according to a study. On the other hand, polyunsaturated fat intake appears protective.

Saturated fat intake ups risk of several cancers

15 May 2026

Semaglutide may be beneficial to individuals with alcohol use disorder, obesity

14 May 2026

In treatment-seeking individuals with alcohol use disorder and obesity, semaglutide appears to help reduce alcohol consumption, as shown in a study.

Semaglutide may be beneficial to individuals with alcohol use disorder, obesity

14 May 2026

Eating behaviours shape body composition of adolescents

13 May 2026 by

Eating-related behaviours among adolescents are significantly associated with body composition, with variations across domains and by sex, suggests a study.

Eating behaviours shape body composition of adolescents

13 May 2026

Original New Drug Application Approvals by US FDA (16-30 April 2026)

11 May 2026

New drug applications approved by US FDA as of 16-30 April 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.